Clinical Trials

A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer


Study ID
AFT-38 PATINA

NCT Number
NCT02947685 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0182

Principle Investigator
Dr. Deena Graham

Phase
III

Sponsor
Alliance


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now